Small Pharma (AgeTech UK) NeuroTech
Psychedelics for depression.Forging a new path in pharmaceutical development by bridging the gap between academia and industry. With specific experience in IP and the drug development process, they integrate a robust IP strategy with the development plan required to guide close-to-clinic candidates through the clinical trials necessary to demonstrate proof-of-concept in patients.
Connections from
Headquarters:
United Kingdom
Employee Number:
N/A
Founded Date:
N/A
Investment Stage:
N/A
Technology:
AgeTech Companies
Investor Type:
N/A
Number Of Exists:
N/A
Industry:
UK AgeTech 2020
Funding Status:
N/A